228 related articles for article (PubMed ID: 36742301)
1. Chemokines and chemokine receptors in Behçet's disease.
Li Z; Cheng L; Zhan H; Li Y
Front Immunol; 2023; 14():1109147. PubMed ID: 36742301
[TBL] [Abstract][Full Text] [Related]
2. Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD.
Dalghous AM; Freysdottir J; Fortune F
Scand J Rheumatol; 2006; 35(6):472-5. PubMed ID: 17343257
[TBL] [Abstract][Full Text] [Related]
3. Immunopathogenesis of Behcet's Disease.
Tong B; Liu X; Xiao J; Su G
Front Immunol; 2019; 10():665. PubMed ID: 30984205
[TBL] [Abstract][Full Text] [Related]
4. Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis?
Pay S; Musabak U; Simsek I; Erdem H; Pekel A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S21-6. PubMed ID: 17949547
[TBL] [Abstract][Full Text] [Related]
5. Behçet's disease: An immunogenetic perspective.
Salmaninejad A; Zamani MR; Shabgah AG; Hosseini S; Mollaei F; Hosseini N; Sahebkar A
J Cell Physiol; 2019 Jun; 234(6):8055-8074. PubMed ID: 30341905
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations.
Houman H; Hamzaoui A; Ben Ghorbal I; Khanfir M; Feki M; Hamzaoui K
J Autoimmun; 2004 Nov; 23(3):267-73. PubMed ID: 15501397
[TBL] [Abstract][Full Text] [Related]
7. Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease.
Suzuki N; Nara K; Suzuki T
Clin Med Res; 2006 Jun; 4(2):147-51. PubMed ID: 16809408
[TBL] [Abstract][Full Text] [Related]
8. Immunopathogenesis of ocular Behçet's disease.
Park UC; Kim TW; Yu HG
J Immunol Res; 2014; 2014():653539. PubMed ID: 25061613
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil, NETs and Behçet's disease: A review.
Le Joncour A; Cacoub P; Boulaftali Y; Saadoun D
Clin Immunol; 2023 May; 250():109318. PubMed ID: 37019424
[TBL] [Abstract][Full Text] [Related]
10. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.
Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G
Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603
[TBL] [Abstract][Full Text] [Related]
11. CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet's disease.
Lee SJ; Kang SE; Kang EH; Choi BY; Masek-Hammerman K; Syed J; Zhan Y; Neff-Phillips K; Park JK; Lee EY; Lee EB; Song YW
Sci Rep; 2017 Nov; 7(1):14720. PubMed ID: 29116188
[TBL] [Abstract][Full Text] [Related]
12. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between serum IL-9 levels and Behçet's disease.
Nouri-Vaskeh M; Malek Mahdavi A; Khabbazi A; Jadideslam G
Immunol Lett; 2019 Jul; 211():23-27. PubMed ID: 31095970
[TBL] [Abstract][Full Text] [Related]
14. Performance of diagnostic criteria in pediatric Behçet's disease.
Kurt T; Aydın F; Sezer M; Tekgöz PN; Tekin ZE; Çelikel E; Karagöl C; Coşkun S; Acar B
Rheumatol Int; 2022 Jan; 42(1):127-132. PubMed ID: 33449161
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
[TBL] [Abstract][Full Text] [Related]
16. The clinical feature of Behçet's disease in Northeastern China.
Shang Y; Han S; Li J; Ren Q; Song F; Chen H
Yonsei Med J; 2009 Oct; 50(5):630-6. PubMed ID: 19881965
[TBL] [Abstract][Full Text] [Related]
17. The Roles of Monocytes and Macrophages in Behçet's Disease With Focus on M1 and M2 Polarization.
Hirahara L; Takase-Minegishi K; Kirino Y; Iizuka-Iribe Y; Soejima Y; Yoshimi R; Nakajima H
Front Immunol; 2022; 13():852297. PubMed ID: 35359926
[TBL] [Abstract][Full Text] [Related]
18. Large-vessel thrombosis in intestinal Behçet's disease complicated with myelodysplastic syndrome and trisomy 8.
Chen HC; Chiu YM
World J Gastroenterol; 2012 Mar; 18(10):1137-40. PubMed ID: 22416191
[TBL] [Abstract][Full Text] [Related]
19. Behçet's disease and risk of vascular events.
Balta S; Balta I; Ozturk C; Celik T; Iyisoy A
Curr Opin Cardiol; 2016 Jul; 31(4):451-7. PubMed ID: 27152661
[TBL] [Abstract][Full Text] [Related]
20. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease.
Ben Ahmed M; Houman H; Miled M; Dellagi K; Louzir H
Arthritis Rheum; 2004 Jul; 50(7):2291-5. PubMed ID: 15248229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
